加巴喷丁治疗糖尿病周围神经痛患者的临床疗效及对血清TNF-α、IL-6的影响

加巴喷丁治疗糖尿病周围神经痛患者的临床疗效及对血清TNF-α、IL-6的影响

任廷和

新乡市第二人民医院

收稿日期:2017-10-27 修回日期:2017-11-13 出版日期:2017-12-25 发布日期:2017-12-25

Clinical Efficacy of Gabapentin in Treatment of Diabetic Peripheral Neuropathic Pain and Its Influence on Serum TNF-α and IL-6

Ren Tinghe

Xinxiang second people''s hospital

Received:2017-10-27 Revised:2017-11-13 Online:2017-12-25 Published:2017-12-25

摘要/Abstract

摘要： 目的：探讨采用加巴喷丁治疗糖尿病周围神经痛患者的临床疗效及对血清TNF-α、IL-6的影响。结果：选取我院2015年9月~2017年2月78例糖尿病周围神经痛患者，按治疗方案的分为常规组和研究组，各39例。对常规组患者进行常规降血糖治疗，研究组在此基础上给予加巴喷丁进行干预，并将两组患者血清TNF-α、IL-6水平、VAS评分及用药后不良反应发生率进行对比。结果：研究组患者TNF-α、IL-6水平分别为（6.27±1.25）ng?L-1、（5.92±3.47）ng?L-1，显著低于常规组的（9.35±1.40）ng?L-1、（8.43±4.05）ng?L-1，两组对比具有统计学意义，P<0.05；研究组患者VAS评分为（3.72±0.39）分，常规组患者为（7.34±0.40）分，差异具有显著性，P<0.05；研究组患者用药后不良反应发生率为7.69%，显著低于常规组患者的43.59%，两组对比具有统计学意义，P<0.05。结论：采用加巴喷丁对糖尿病周围神经痛患者进行治疗，可有效降低患者血清TNF-α、IL-6水平，减轻患者疼痛程度，进一步提升临床疗效，且用药安全性较高，具备临床意义与价值。

Abstract: Objective： To investigate the clinical efficacy of gabapentin in treatment of diabetic peripheral neuropathic pain (DPNP) and its influence on serum TNF-α and IL-6. Methods： 78 DPNP patients in Xinxiang Second People′s Hospital from September 2015 to February 2017 were selected， and they were divided into routine group and research group by treatment regimens， 39 cases in each group. Routine group was given hpyerglycemic therapy， while research group was given gabapentin based on routine group. The levels of serum TNF-α and IL-6， VAS score and incidence of adverse reactions were compared between the two groups. Results：The levels of TNF-α and IL-6 in research group [(6.27±1.25)ng?L-1， (5.92±3.47)ng?L-1] were lower than routine group [(9.35±1.40)ng?L-1， (8.43±4.05)ng?L-1] (P<0.05)； The VAS scores of research group and routine group were (3.72±0.39)points and (7.34±0.40)points， with statistical difference (P<0.05)； The incidence of adverse reactions in research group was 7.69%， which was lower than 43.59% in routine group (P<0.05). Conclusion：Gabapentin in treatment of DPNP can effectively decrease the levels of serum TNF-α and IL-6， reduce pain degree， increase clinical efficacy and have higher drug safety， which has clinical significance and value.

任廷和. 加巴喷丁治疗糖尿病周围神经痛患者的临床疗效及对血清TNF-α、IL-6的影响[J]. .

Ren Tinghe. Clinical Efficacy of Gabapentin in Treatment of Diabetic Peripheral Neuropathic Pain and Its Influence on Serum TNF-α and IL-6[J]. .

参考文献

[1]倪桂莲,崔融,林翔东等.加巴喷丁治疗糖尿病周围神经痛患者的临床疗效及对血清TNF-α、IL-6的影响[J].中风与神经疾病杂志,2015,32(1):48-51.
[2]王爱荣,马云龙,刘波涛等.加巴喷丁联合腺苷钴胺治疗糖尿病痛性神经病变的临床初步观察[J].中国糖尿病杂志,2017,25(5):420-423.
[3]丁远远,姚鹏.加巴喷丁联合神经妥乐平治疗痛性糖尿病周围神经病变的临床观察[J].中国现代医学杂志,2015,25(23):86-90.
[4]何颖,万成福,宋涛等.加巴喷丁联合小剂量丁丙诺菲透皮贴治疗糖尿病周围神经痛的临床观察[J].中国医师杂志,2015,17(10):1465-1467.
[5]秦丽娜.盐酸羟考酮控释片复合加巴喷丁治疗老年糖尿病性神经痛的疗效[J].中国实用医刊,2016,43(4):77-78.
[6]王峰.加巴喷丁治疗糖尿病周围神经痛患者的临床疗效及对血清TNF-α、IL-6的影响[J].中国实用医药,2016,11(13):135-136.
[7]曾明.加巴喷丁联合硫辛酸治疗痛性糖尿病周围神经病变的疗效观察[J].世界临床医学,2015,9(2):28-30.
[8]李书娟.加巴喷丁胶囊联合氨酚羟考酮片治疗老年糖尿病周围神经痛的疗效观察[J].国际医药卫生导报,2016,22(7):981-983.
[9]张桂芬.甲钴胺联合加巴喷丁治疗糖尿病痛性神经病变疗效分析[J].中国实用医刊,2016,43(12):100-101.
[10]张晓兰,袁红宇.加巴喷丁治疗糖尿病周围神经痛的Meta分析[J].药物评价研究,2015,38(5):557-562.
[11]何颖,万成福,宋涛.加巴喷丁联合小剂量丁丙诺菲透皮贴治疗糖尿病周围神经痛的临床观察[J].中国医师杂志,2015,17(10):1465-1467.
[12]江天,陈赟,张虹.加巴喷丁与卡马西平治疗糖尿病神经痛的临床疗效对比[J].实用临床医药杂志,2014,18(23):23-25.
[13]倪桂莲,崔融,陈干明,等.加巴喷丁对糖尿病神经痛大鼠痛敏和脊髓Glu及下丘脑JNK的影响[J].中华全科医学,2015,13(11):1757-1759.
[14]徐洪刚,吴媛媛,王昊.盐酸羟考酮控释片复合加巴喷丁治疗老年糖尿病性神经痛的效应观察[J].医学与哲学,2015,36(4):32-34.
[15]岑晴,莫钧婷,钟润芬,等.加巴喷丁联合α-硫辛酸治疗痛性糖尿病周围神经病变的疗效观察[J].疑难病杂志,2015,9(6):579-581.